Tornier to acquire Nexia Orthopedics:
This article was originally published in Clinica
Executive Summary
Orthopaedic extremity device developer Tornier has agreed to acquire Nexa Orthopedics, a fellow specialist in extremities. Nexa is based in San Diego, California, and was founded by HealthpointCapital in 2004. Financial terms of the acquisition were not disclosed. Tornier notes that the deal will expand its technology base with new implantable device materials and coatings as well as enlarging its portfolio of products for surgeons performing procedures on shoulders, arms, hands, feet and ankles. Tornier's US business in Eden Prairie, Minnesota, is part of a family business based in Grenoble, France. In July 2006, Warburg Pincus acquired a majority stake in the company, and Douglas Kohrs, former president and CEO of American Medical Systems, was installed as president and CEO of Tornier, replacing Alain Tornier, who became chairman.
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.